Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: smh who wrote (5341)	1/6/2002 8:16:14 PM
From: Cosmo Daisey	of 52153

smh, The Gilder Biotech letter has been out for several months. It is written by Scott Gottlieb MD. The letter is well written and easy to read. It seems the letter closely follows the work of George Wolff who runs a research firm whose customers are institutions and funds investigating and investing in biotech stocks. George wrote "The Biotech Investors Bible" which I would highly recommend for anyone interested in bio investing. The book is the result of requests for reports he wrote on bio companies for customers so he decided to put them together in a book. (available @ Amazon) The letter is $250 a year and worth it if you can get one great stock from it. If you are interested I can post the current portfolio suggestions. cdaisey@gilder-is-great-com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next